163 related articles for article (PubMed ID: 30430552)
1. Rifampicin alone may be enough: is it time to abandon the classic oral clindamycin-rifampicin combination for hidradenitis suppurativa?
Albrecht J; Barbaric J; Nast A
Br J Dermatol; 2019 Apr; 180(4):949-950. PubMed ID: 30430552
[No Abstract] [Full Text] [Related]
2. Clindamycin alone may be enough. Is it time to abandon rifampicin for hidradenitis suppurativa?
Caposiena Caro RD; Bianchi L
Br J Dermatol; 2019 May; 180(5):1262. PubMed ID: 30604861
[No Abstract] [Full Text] [Related]
3. Clindamycin alone may be enough. Is it time to abandon rifampicin for hidradenitis suppurativa? Reply from the authors.
Albrecht J; Barbaric J; Nast A
Br J Dermatol; 2019 May; 180(5):1262-1263. PubMed ID: 30604869
[No Abstract] [Full Text] [Related]
4. Clindamycin versus clindamycin plus rifampicin in hidradenitis suppurativa treatment: Clinical and ultrasound observations.
Caposiena Caro RD; Cannizzaro MV; Botti E; Di Raimondo C; Di Matteo E; Gaziano R; Bianchi L
J Am Acad Dermatol; 2019 May; 80(5):1314-1321. PubMed ID: 30502416
[TBL] [Abstract][Full Text] [Related]
5. Prolonged clindamycin and rifampicin for hidradenitis suppurativa: resist to prevent resistance.
Hambly R; Kirby B
Br J Dermatol; 2019 Apr; 180(4):702-703. PubMed ID: 30933345
[No Abstract] [Full Text] [Related]
6. Oral ofloxacin and clindamycin as an alternative to the classic rifampicin-clindamycin in hidradenitis suppurativa: retrospective analysis of 65 patients.
Delaunay J; Villani AP; Guillem P; Tristan A; Boibieux A; Jullien D
Br J Dermatol; 2018 Jan; 178(1):e15-e16. PubMed ID: 28626900
[No Abstract] [Full Text] [Related]
7. Clindamycin and rifampicin combination therapy for hidradenitis suppurativa.
Mendonça CO; Griffiths CE
Br J Dermatol; 2006 May; 154(5):977-8. PubMed ID: 16634904
[TBL] [Abstract][Full Text] [Related]
8. Long-term clinical safety of clindamycin and rifampicin combination for the treatment of hidradenitis suppurativa: a strategy to reduce side-effects, improving patients' compliance.
Marasca C; Masarà A; Annunziata MC; Bettoli V; Luciano MA; Fabbrocini G
Br J Dermatol; 2019 Apr; 180(4):949. PubMed ID: 30430549
[No Abstract] [Full Text] [Related]
9. Lymecycline vs. clindamycin plus rifampicin in hidradenitis suppurativa treatment: clinical and ultrasonography evaluation.
Caposiena Caro RD; Molinelli E; Brisigotti V; Offidani A; Bianchi L
Clin Exp Dermatol; 2021 Jan; 46(1):96-102. PubMed ID: 32683727
[TBL] [Abstract][Full Text] [Related]
10. Oral clindamycin and rifampicin combination therapy for hidradenitis suppurativa: a prospective study and 1-year follow-up.
Dessinioti C; Zisimou C; Tzanetakou V; Stratigos A; Antoniou C
Clin Exp Dermatol; 2016 Dec; 41(8):852-857. PubMed ID: 27753139
[TBL] [Abstract][Full Text] [Related]
11. Rifampicin and clindamycin for hidradenitis.
Wall D; Kirby B
J Am Acad Dermatol; 2011 Apr; 64(4):790. PubMed ID: 21414503
[No Abstract] [Full Text] [Related]
12. Effectiveness of clindamycin and rifampicin combination therapy in hidradenitis suppurativa: a 6-month prospective study.
Yao Y; Jørgensen AR; Ring HC; Thomsen SF
Br J Dermatol; 2021 Mar; 184(3):552-553. PubMed ID: 33000461
[No Abstract] [Full Text] [Related]
13. The efficacy and tolerability of tetracyclines and clindamycin plus rifampicin for the treatment of hidradenitis suppurativa: Results of a prospective European cohort study.
van Straalen KR; Tzellos T; Guillem P; Benhadou F; Cuenca-Barrales C; Daxhelet M; Daoud M; Efthymiou O; Giamarellos-Bourboulis EJ; Jemec GBE; Katoulis AC; Koenig A; Lazaridou E; Marzano AV; Matusiak Ł; Molina-Leyva A; Moltrasio C; Pinter A; Potenza C; Romaní J; Saunte DM; Skroza N; Stergianou D; Szepietowski J; Trigoni A; Vilarrasa E; van der Zee HH
J Am Acad Dermatol; 2021 Aug; 85(2):369-378. PubMed ID: 33484766
[TBL] [Abstract][Full Text] [Related]
14. Long-term clinical safety of clindamycin and rifampicin combination for the treatment of hidradenitis suppurativa. A Critically Appraised Topic.
Albrecht J; Baine PA; Ladizinski B; Jemec GB; Bigby M
Br J Dermatol; 2019 Apr; 180(4):749-755. PubMed ID: 30281779
[TBL] [Abstract][Full Text] [Related]
15. KITTEN following CAT on the long-term use of rifampicin in hidradenitis suppurativa and effectiveness of oral contraceptives.
Yazdanyar S; Jemec GB
Br J Dermatol; 2019 Jul; 181(1):225-226. PubMed ID: 30907428
[No Abstract] [Full Text] [Related]
16. Interruption of oral clindamycin plus rifampicin therapy in patients with hidradenitis suppurativa: An observational study to assess prevalence and causes.
Schneller-Pavelescu L; Vergara-de Caso E; Martorell A; Romaní J; Lázaro M; Vilarrasa E; Díaz-Ley B; Vázquez-Osorio I; Segura Palacios JM; Azaña JM; González-López MA; Cañueto J; Molina-Leyva A; Leiva-Salinas M; Navarro-Triviño FJ; Sánchez-Payá J; Pascual JC
J Am Acad Dermatol; 2019 May; 80(5):1455-1457. PubMed ID: 30630028
[No Abstract] [Full Text] [Related]
17. Treatment of hidradenitis suppurativa with rifampicin: have we forgotten tuberculosis?
Mendes-Bastos P; Macedo R; Duarte R
Br J Dermatol; 2017 Oct; 177(4):e150-e151. PubMed ID: 28718933
[No Abstract] [Full Text] [Related]
18. Efficacy of short-term intravenous clindamycin prior to oral clindamycin-rifampicin treatment in hidradenitis suppurativa: a retrospective case series.
Nikolakis G; Kristandt A; Hauptmann M; Becker M; Zouboulis CC
Br J Dermatol; 2021 Dec; 185(6):1270-1272. PubMed ID: 34270785
[No Abstract] [Full Text] [Related]
19. Adalimumab versus Rifampicin Plus Clindamycin for the Treatment of Moderate to Severe Hidradenitis Suppurativa: A Retrospective Study.
Marasca C; Annunziata MC; Villani A; Volpe S; Marasca D; Fabbrocini G
J Drugs Dermatol; 2019 May; 18(5):437-438. PubMed ID: 31141853
[TBL] [Abstract][Full Text] [Related]
20. Why rifampin (rifampicin) is a key component in the antibiotic treatment of hidradenitis suppurativa: a review of rifampin's effects on bacteria, bacterial biofilms, and the human immune system.
Scheinfeld N
Dermatol Online J; 2016 Jun; 22(6):. PubMed ID: 27617596
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
